Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v1-EN
Language English English
Date Updated 2019-01-31 2018-12-04
Drug Identification Number 02448319 02448319
Brand name ACT DEXTROAMPHETAMINE SR ACT DEXTROAMPHETAMINE SR
Common or Proper name DEXTROAMPHETAMINE DEXTROAMPHETAMINE
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients DEXTROAMPHETAMINE SULFATE DEXTROAMPHETAMINE SULFATE
Strength(s) 10MG 10MG
Dosage form(s) CAPSULE (SUSTAINED-RELEASE) CAPSULE (SUSTAINED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100 100
ATC code N06BA N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-12-03 2018-12-03
Estimated end date 2019-02-28 2018-12-30
Actual end date
Shortage status Actual shortage Actual shortage
Company comments
Health Canada comments